サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788294

植物由来のAPIの世界市場

Plant-based APIs

出版日
ページ情報
英文 197 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
植物由来のAPIの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

植物由来のAPIの世界市場は2030年までに478億米ドルに達する見込み

2024年に339億米ドルと推定される植物由来のAPIの世界市場は、2024年から2030年にかけてCAGR 5.9%で成長し、2030年には478億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるアルカロイドは、CAGR6.8％を記録し、分析期間終了時には160億米ドルに達すると予想されます。アントシアニン分野の成長率は、分析期間中CAGR 4.4％と推定されます。

米国市場は89億米ドルと推定、中国はCAGR 5.6％で成長すると予測

米国の植物由来のAPI市場は2024年に89億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに76億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.3％と5.0％と予測されています。欧州では、ドイツがCAGR約4.6％で成長すると予測されています。

世界の植物由来医薬品有効成分（API）市場- 主要動向と促進要因のまとめ

なぜ植物由来のAPIは持続可能な医薬品イノベーションの次のフロンティアなのか？

世界の植物由来API市場は、製薬業界がよりクリーンで環境に優しく、持続可能な医薬品開発へと舵を切る中で、強い勢いを見せています。植物やハーブ由来の医薬品有効成分（API）は、長い間、伝統的な医療システムにおいて基礎的な役割を果たしてきたが、近年、植物由来の化合物が、現代的な医薬品製剤のための、実行可能で効果的かつスケーラブルなソリューションとして再び注目を集めています。この変化の背景には、天然治療薬に対する消費者の需要の高まりと、合成薬の副作用に対する意識の高まりがあります。その結果、製薬会社は、がん、心血管疾患、疼痛管理、メンタルヘルスなどの治療分野に向けて、植物性医薬品、アルカロイド、テルペノイド、配糖体の探索を進めています。

消費者の認識を超えて、WHO、EMA、USFDAなどの規制機関は、ハーブや植物由来のAPIを評価する枠組みを正式に作り始め、エビデンスに基づく医療における役割を正当化しています。また、植物由来のAPIはアロパシー製剤と補完的製剤の両方に統合され、ハイブリッド治療薬のイノベーションを促進しています。クルクミン、レスベラトロール、カンナビジオール（CBD）、アルテミシニンなど、植物由来の化合物の有効性と安全性を裏付ける臨床エビデンスが蓄積されつつあり、市場は科学的信頼性を獲得しつつあります。さらに、個別化医療や予防ヘルスケアの人気の高まりにより、毒性が低く、生体適合性に優れ、患者のアドヒアランスを向上させる植物由来原薬の需要が高まっています。

抽出・精製における技術革新はAPIの情勢をどのように再定義しているか？

抽出、精製、標準化における技術の進歩は、植物由来のAPIの生産に革命をもたらし、より信頼性が高く、一貫性があり、製薬上有効なものとなっています。従来の溶媒抽出技術は、超臨界CO2抽出、超音波アシスト抽出、マイクロ波アシスト技術などのグリーン抽出法に取って代わられたり、補足されることが多くなってきています。これらの技術革新は、より高い収量、より優れた生物学的利用能、環境への影響の低減を保証し、植物由来のAPIを合成品と比較してより競争力のあるものにしています。さらに、クロマトグラフィー、分子蒸留、発酵技術の進歩により、医薬品レベルの純度で生物活性成分を正確に単離することが可能になっています。

植物由来原薬の長年の課題であった標準化と再現性は、統合的な品質管理システムや、原料植物の真正性と力価を検証するDNAバーコード技術によって解決されつつあります。植物細胞培養や代謝工学を含むバイオテクノロジー的アプローチも、希少化合物や絶滅危惧化合物を野生資源を採取することなく大規模に生産するために利用されています。これは、乱獲が生物多様性へのリスクとなるパクリタキセル（イチイの木から）やビンクリスチン（シソ科の植物から）などの化合物にとって特に貴重です。このような科学的進歩は、植物由来のAPIの医薬品としての有用性を拡大するだけでなく、持続可能性、安全性プロファイル、世界の医薬品生産のための拡張性をも向上させています。

植物由来のAPIの需要を牽引しているエンドユーザー分野は？

植物由来のAPIの需要は、複数の製薬・ヘルスケア業界で拡大しています。医療用医薬品市場では、抗炎症薬、抗マラリア薬、抗がん剤、心血管治療薬などの治療領域で使用されることが多くなっています。例えば、アルテミシニンベースの併用療法（ACT）は依然としてマラリア治療のゴールドスタンダードであり、カンナビジオールやTHCベースのAPIはてんかん、慢性疼痛、不安障害の治療薬として研究・商品化されています。慢性疾患の世界の負担が増加の一途をたどるなか、長期的な安全性と副作用の少ない植物由来の化合物への関心が高まっています。

処方薬に加え、一般用医薬品（OTC）製剤と栄養補助食品も急成長している最終用途分野です。ハーブの咳止めシロップ、消化補助剤、睡眠サプリメント、免疫増強剤などの製品は、標準化された植物由来のAPIを採用することが多くなっています。アロエベラエキス、ティーツリーオイル誘導体、バクチオール（植物性レチノール代替品）などの植物性化合物が局所治療や化粧品に使用されています。動物用医薬品も有望な分野で、特に家畜への抗生物質使用が抑制されている地域では、動物の疼痛、消化、感染症の管理にハーブ原薬が使用されています。これらの原薬の使用拡大により、その多用途性、消費者へのアピール、商業的可能性が浮き彫りになっています。

世界の植物由来API市場の成長の原動力は？

植物由来API市場の成長は、技術の進歩、最終用途の多様化、進化する製薬および規制状況に関連するいくつかの要因によって促進されます。特に、抗生物質耐性や慢性疾患が治療の優先順位を再構築するにつれて、より安全で持続可能な天然由来の医薬品原料に対する需要が高まっていることが主な要因です。消費者やヘルスケアプロバイダーは、副作用が少なく化学的負担の少ない医薬品を強く好む傾向にあり、長期的な治療計画にとって植物由来のAPIはより魅力的なものとなっています。さらに、個別化医療や統合医療へのシフトは、伝統的な知恵と現代的な送達システムを組み合わせた植物製剤の技術革新を促しています。

抽出と標準化における技術的な飛躍的進歩は、植物由来のAPIの拡張性と再現性を著しく高め、効能と一貫性に関する歴史的な制限に対処しています。これと並行して、バイオテクノロジーを駆使した合成法や組織培養法が天然資源への圧力を軽減し、価値の高い植物性化合物の年間を通じた制御された生産を可能にしています。需要面では、クリーンラベルの治療薬に対する消費者の関心の高まりと、植物をベースとしたライフスタイルの台頭により、医薬品、OTC医薬品、ウェルネス製品への植物性原薬の配合が加速しています。WHOのモノグラフ、EMAのハーブガイドライン、USFDAの植物医薬品開発フレームワークなどの規制の進化は、製薬会社が植物由来のAPIを中心とした研究開発パイプラインに投資することをさらに促しています。これらの要因が相まって、世界の製薬業界では、植物由来APIを将来の治療イノベーションの重要な要素として位置づけるという、強固で永続的なシフトが起こりつつあります。

セグメント

分子タイプ（アルカロイド、アントシアニン、フラボノイド、フェノール酸、テルペノイド、リグニン＆スチルベン、その他）、最終用途（医薬品、栄養補助食品、ハーブベース、その他）

調査対象企業の例

  • Abbott Laboratories
  • Afriplex
  • Alchem International
  • Alkaloids Corporation
  • BASF SE
  • Bright Green Corporation
  • Centroflora Group
  • DSM-Firmenich
  • Indena S.p.A
  • Kerry Group plc
  • Mallinckrodt Pharmaceuticals
  • Phyton Biotech
  • Protalix BioTherapeutics
  • Roquette Freres
  • Sami-Sabinsa Group
  • Shaanxi Jiahe Phytochem Co., Ltd.
  • Sichuan Xieli Pharmaceutical
  • Teva Pharmaceutical Industries Ltd.
  • Veranova
  • Xi'an Greena Biotech Co., Ltd.

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32584

Global Plant-based APIs Market to Reach US$47.8 Billion by 2030

The global market for Plant-based APIs estimated at US$33.9 Billion in the year 2024, is expected to reach US$47.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Alkaloids, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$16.0 Billion by the end of the analysis period. Growth in the Anthocyanin segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.9 Billion While China is Forecast to Grow at 5.6% CAGR

The Plant-based APIs market in the U.S. is estimated at US$8.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Plant-Based Active Pharmaceutical Ingredients (API) Market - Key Trends & Drivers Summarized

Why Are Plant-Based APIs the Next Frontier in Sustainable Pharma Innovation?

The global plant-based API market is witnessing strong momentum as the pharmaceutical industry pivots toward cleaner, greener, and more sustainable drug development practices. Active pharmaceutical ingredients (APIs) derived from botanicals and herbal sources have long played a foundational role in traditional medicine systems, but recent years have seen a resurgence of interest in plant-derived compounds as viable, efficacious, and scalable solutions for modern drug formulations. This shift is driven in part by increasing consumer demand for natural therapeutics and growing awareness around the side effects of synthetic drugs. Consequently, pharmaceutical companies are exploring phyto-pharmaceuticals, alkaloids, terpenoids, and glycosides for therapeutic areas including oncology, cardiovascular diseases, pain management, and mental health.

Beyond consumer perception, regulatory agencies such as the WHO, EMA, and USFDA have begun to formalize frameworks for evaluating herbal and plant-based APIs, thus legitimizing their role in evidence-based medicine. Plant-based APIs are also being integrated into both allopathic and complementary formulations, driving innovation in hybrid therapeutics. With a growing body of clinical evidence supporting the efficacy and safety of plant-based compounds-such as curcumin, resveratrol, cannabidiol (CBD), and artemisinin-the market is gaining scientific credibility. Additionally, the increasing popularity of personalized medicine and preventive healthcare is steering demand for plant-derived APIs that offer lower toxicity, better biocompatibility, and improved patient adherence.

How Is Innovation in Extraction and Purification Redefining the API Landscape?

Technological advancements in extraction, purification, and standardization are revolutionizing the production of plant-based APIs, making them more reliable, consistent, and pharmaceutically viable. Conventional solvent extraction techniques are increasingly being replaced or supplemented by green extraction methods such as supercritical CO2 extraction, ultrasound-assisted extraction, and microwave-assisted techniques. These innovations ensure higher yield, better bioavailability, and reduced environmental impact, making plant-based APIs more competitive with their synthetic counterparts. Additionally, advancements in chromatography, molecular distillation, and fermentation technologies are enabling precise isolation of bioactive constituents with pharmaceutical-grade purity.

Standardization and reproducibility, long-standing challenges for botanical APIs, are being addressed through integrated quality control systems and DNA barcoding techniques that verify the authenticity and potency of raw plant materials. Biotechnological approaches, including plant cell culture and metabolic engineering, are also being used to produce rare or endangered compounds at scale without harvesting wild resources. This is particularly valuable for compounds such as paclitaxel (from yew trees) and vincristine (from periwinkle), where overexploitation poses a risk to biodiversity. These scientific advancements are not only expanding the pharmaceutical utility of plant-based APIs but also improving their sustainability, safety profiles, and scalability for global drug production.

Which End-Use Sectors Are Driving Demand for Plant-Based APIs?

The demand for plant-based APIs is expanding across multiple pharmaceutical and healthcare verticals. In the prescription drug market, they are increasingly used in therapeutic areas like anti-inflammatory, antimalarial, anticancer, and cardiovascular drugs-often as the primary active or as adjunctive therapies. For example, artemisinin-based combination therapies (ACTs) remain the gold standard for malaria treatment, while cannabidiol and THC-based APIs are being explored and commercialized for epilepsy, chronic pain, and anxiety disorders. As the global burden of chronic diseases continues to rise, there is growing interest in plant-derived compounds with long-term safety profiles and minimal side effects.

In addition to prescription drugs, over-the-counter (OTC) formulations and nutraceuticals represent a fast-growing end-use segment. Products such as herbal cough syrups, digestion aids, sleep supplements, and immune boosters are increasingly featuring standardized plant-based APIs. These APIs are also gaining traction in dermatology, where botanical compounds like aloe vera extract, tea tree oil derivatives, and bakuchiol (a plant-based retinol alternative) are used in topical treatments and cosmeceuticals. Veterinary pharmaceuticals are another promising area, with herbal APIs being used to manage pain, digestion, and infections in animals-particularly in regions where antibiotic use in livestock is being curbed. The expanding use of these APIs across sectors highlights their versatility, consumer appeal, and commercial viability.

What’s Fueling Growth in the Global Plant-Based API Market?

The growth in the plant-based API market is driven by several factors related to technological advancement, end-use diversification, and evolving pharmaceutical and regulatory landscapes. A major driver is the increasing demand for safer, sustainable, and naturally derived drug ingredients-especially as antibiotic resistance and chronic diseases reshape therapeutic priorities. Consumers and healthcare providers are showing strong preference for medications with fewer side effects and lower chemical burden, making plant-based APIs more attractive for long-term treatment plans. Furthermore, the shift toward personalized and integrative medicine is driving innovation in botanical formulations that combine traditional wisdom with modern delivery systems.

Technological breakthroughs in extraction and standardization have significantly enhanced the scalability and reproducibility of plant-based APIs, addressing historical limitations around potency and consistency. In parallel, biotech-driven synthesis and tissue culture methods are reducing pressure on natural resources and enabling year-round, controlled production of high-value phyto-compounds. On the demand side, growing consumer interest in clean-label therapeutics and the rise of plant-based lifestyles are accelerating the inclusion of botanical APIs in pharmaceuticals, OTC drugs, and wellness products. Regulatory evolution-including WHO monographs, EMA herbal guidelines, and USFDA botanical drug development frameworks-is further encouraging pharmaceutical companies to invest in R&D pipelines centered on plant-based APIs. Altogether, these drivers are catalyzing a robust and enduring shift in global pharma-positioning plant-derived APIs as a key component of future therapeutic innovation.

SCOPE OF STUDY:

The report analyzes the Plant-based APIs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Molecule Type (Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes, Others); End-Use (Pharmaceuticals, Nutraceuticals, Herbal-based, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Afriplex
  • Alchem International
  • Alkaloids Corporation
  • BASF SE
  • Bright Green Corporation
  • Centroflora Group
  • DSM-Firmenich
  • Indena S.p.A
  • Kerry Group plc
  • Mallinckrodt Pharmaceuticals
  • Phyton Biotech
  • Protalix BioTherapeutics
  • Roquette Freres
  • Sami-Sabinsa Group
  • Shaanxi Jiahe Phytochem Co., Ltd.
  • Sichuan Xieli Pharmaceutical
  • Teva Pharmaceutical Industries Ltd.
  • Veranova
  • Xi'an Greena Biotech Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Plant-based APIs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Demand for Natural and Botanical Therapeutics Spurs Adoption of Plant-Based APIs in Pharmaceutical Formulations
    • Growth of Phytopharmaceutical and Herbal Drug Development Strengthens Business Case for Plant-Derived Actives
    • Regulatory Acceptance of Traditional and Ayurvedic Ingredients Promotes Market Entry of Plant-Based APIs
    • Shift Toward Clean Label and Green Chemistry in Pharma Encourages Transition from Synthetic to Botanical API Sources
    • Increased Consumer Trust in Natural Remedies Drives Demand for Plant-Derived APIs in OTC and Preventive Medicine
    • Advancements in Phytochemical Extraction and Purification Techniques Improve Yield and Efficacy of APIs
    • Global Interest in Immunomodulators, Antioxidants, and Anti-Inflammatory Agents Boosts Market for Herbal APIs
    • Expansion of Nutraceutical and Functional Supplement Categories Fuels Dual-Use Plant-Based API Demand
    • Clinical Validation of Traditional Botanicals Enhances Integration into Evidence-Based Modern Therapies
    • Growing Prevalence of Chronic Diseases Supports Use of Plant-Based APIs in Long-Term Management Protocols
    • Sustainability Concerns and Raw Material Transparency Requirements Strengthen Case for Traceable Plant-Based Supply Chains
    • Investment in Ethnobotanical Research and Indigenous Plant Sources Opens New Frontiers in API Discovery
    • Biotech Innovation in Plant Cell Culture and Tissue Engineering Enables Scalable API Production Without Wild Harvesting
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Plant-based APIs Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Plant-based APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Plant-based APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Plant-based APIs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Alkaloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Alkaloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Alkaloids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Anthocyanin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Anthocyanin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Anthocyanin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Flavonoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Flavonoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Flavonoids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Phenolic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Phenolic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Phenolic Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Terpenoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Terpenoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Terpenoids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lignin & Stilbenes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Lignin & Stilbenes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Lignin & Stilbenes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Molecule Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Molecule Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Molecule Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Herbal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Herbal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Herbal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Nutraceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Nutraceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Nutraceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • JAPAN
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • CHINA
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • EUROPE
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Plant-based APIs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Plant-based APIs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Plant-based APIs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • FRANCE
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • GERMANY
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Plant-based APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Plant-based APIs by Molecule Type - Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Plant-based APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Plant-based APIs by End-Use - Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of World 15-Year Perspective for Plant-based APIs by End-Use - Percentage Breakdown of Value Sales for Herbal-based, Other End-Uses, Pharmaceuticals and Nutraceuticals for the Years 2015, 2025 & 2030

IV. COMPETITION